What is Immunotherapy

Immunotherapy — CAR-T therapy revolutionize the cancer treatment

There is a rapidly emerging immunotherapy approach called cancer immunotherapy. This approach consists of collecting and using someone‘s own immune cells to treat their cancer. To learn more…

CAR T-cell therapy is a form of immunotherapy that uses T–cells from a patient’s own immune system to help them fight cancer. Typically, a sample of a patient’s T–cells are collected from their blood, then modified to produce special structures called chimeric antigen receptors (CARs) on their surface. When these CAR T–cells are re–infused into the patient, the new receptors enable them to latch onto and kill specific antigens on the patient’s tumor cells.

CAR T-cell therapy is a form of immunotherapy that uses T–cells from a patient’s own immune system to help them fight cancer.
Currently, CAR T-cell therapy is FDA approved as a standard of care for some forms of aggressive, refractory non-Hodgkin lymphoma and for patients with relapsed or refractory acute lymphoblastic leukemia. CAR T-cell therapy has been shown to be highly effective in fighting these cancers. Clinical trials have shown very promising results in “non-option” end-stage patients with a full recovery of up to 92% in those who possessed Acute Lymphocytic Leukemia. In addition, there are over 800 ongoing trials of CAR T-cell therapy for other forms of blood cancer and solid tumors.

CAR T-Cell therapy’s progress so far

CAR T-cell immunotherapy uses one’s own immune cells to fight cancer

Two CAR T-cell therapies received FDA approval in 2017 for treating B cell leukemia and lymphoma

Both CAR T-cell therapies have reported over 80% response rate in the intended-to-treat cancer patient group for the patients who fail chemotherapy and radiation

Thousands of cancer patients have entered remission following CAR T-cell treatment

Billions of dollars are currently funding over 800 CAR T-cell clinical trials worldwide targeting every different cancer types.

With increased focus and technology, many more breakthroughs are expected in fighting against cancer with our own cells

Subscribe to Our Newsletter & Special Promotions

Disclaimer: The use of cord blood and immune cells is determined by the treating physician and manufacturer of the final products and is influenced by many factors, including the patient's medical condition, the characteristics of the sample, and whether the immune cells should be further modified or expanded. Cord blood has established uses in transplant medicine; however, its use in regenerative medicine is still being researched. There is no guarantee that potential medical applications being studied in the laboratory or clinical trials will become available. Cord tissue use is still in early research stages, and there is no guarantee that treatments using cord tissue will be available in the future. Cord tissue is stored whole. Additional processing prior to use will be required to extract and prepare any of the multiple cell types from cryopreserved cord tissue. Immune cells has established uses in certain blood cancer treatment; however, its use in solid cancer is still being researched. There is no guarantee that treatments being studied in the laboratory, clinical trials, or other experimental treatments will be available in the future.

HealthBanks cryopreserves immune cells that have been collected from an individual for potential future cellular therapy use. HealthBanks does not provide medical advice, treatment or care. The use of cryopreserved cells for future immunotherapies is not guaranteed. Much is yet unknown about the future of immunotherapy and the immune cells that have been cryopreserved. The use of cryopreserved cells by commercial manufacturers for CAR-T therapy production is not currently approved by the FDA. There is active research ongoing, however, there is no guarantee that your cryopreserved cells will have a future therapeutic use. Only your health care professional can help you evaluate whether your cells might be used and if so, how they might be used. HealthBanks and its shareholders, directors, officers, agents, employees, affiliates, network of providers and provider facilities, will not be liable to you or any other party for claims relating to sample collection or if your cells cannot be used, or if any harm, injury, damage or loss results from the use of your cells. For more information, please refer to HealthBanks Service Agreement.